Supplemental material
Open access
4,109
Views
1
CrossRef citations to date
0
Altmetric
Original Article
A novel intragastric balloon for treatment of obesity and type 2 diabetes. A two-center pilot trial
Christer Julseth Tønnesena Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway;b Clinical Effectiveness Research Group, Oslo University Hospital, Oslo, Norway;c Section of Gastroenterology, Department of Transplantation Medicine, Oslo University Hospital, Oslo, NorwayCorrespondence[email protected]
https://orcid.org/0000-0002-9003-433XView further author information
, https://orcid.org/0000-0002-9003-433XView further author information
Jøran Hjelmesæthd Morbid Obesity Centre, Vestfold Hospital Trust, Tønsberg, Norway;e Department of Endocrinology, Morbid Obesity and Preventive Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, NorwayView further author information
, Dag Hofsød Morbid Obesity Centre, Vestfold Hospital Trust, Tønsberg, NorwayView further author information
, Serena Tonstadf Preventive Cardiology, Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital Aker, Oslo, NorwayView further author information
, Jens Kristoffer Herteld Morbid Obesity Centre, Vestfold Hospital Trust, Tønsberg, NorwayView further author information
, Eli Heggenf Preventive Cardiology, Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital Aker, Oslo, NorwayView further author information
, Line Kristin Johnsond Morbid Obesity Centre, Vestfold Hospital Trust, Tønsberg, NorwayView further author information
, Tor Erik Mathiseng Department of Gastroenterology, Vestfold Hospital Trust, Tønsberg, NorwayView further author information
, Mette Kalagera Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway;b Clinical Effectiveness Research Group, Oslo University Hospital, Oslo, NorwayView further author information
, Paulina Wieszczya Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway;b Clinical Effectiveness Research Group, Oslo University Hospital, Oslo, Norway;h Department of Gastroenterology, Hepatology and Clinical Oncology, Centre of Postgraduate Medical Education, Warsaw, PolandView further author information
, Asle W. Medhusi Department of Gastroenterology, Oslo University Hospital, Oslo, NorwayView further author information
, Magnus Løberga Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway;b Clinical Effectiveness Research Group, Oslo University Hospital, Oslo, NorwayView further author information
, Lars Aabakkena Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway;b Clinical Effectiveness Research Group, Oslo University Hospital, Oslo, Norway;c Section of Gastroenterology, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway;j Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, NorwayView further author information
& Michael Bretthauera Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway;b Clinical Effectiveness Research Group, Oslo University Hospital, Oslo, Norway;c Section of Gastroenterology, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway;k Institute of Clinical Medicine, University of Tromsø, Tromsø, NorwayView further author information
show all
Pages 232-238
|
Received 17 Sep 2021, Accepted 11 Oct 2021, Published online: 29 Oct 2021
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.